Access Statistics for Aidan Hollis

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Contractual Approach to the Gray Market 0 0 2 417 1 3 6 2,056
Complementarity, Competition and Institutional Development: The Irish Loan Funds through Three Centuries 0 0 1 285 0 2 6 1,277
Exclusivity Restrictions in Markets with Adverse Selection: The Case of Extended Warranties 0 0 0 105 0 0 3 826
Generic drug pricing in Canada: components of the value-chain 0 0 0 96 0 0 4 282
Microcredit in Pre-Famine Ireland 0 1 4 329 1 4 10 1,706
Orphan drug pricing and costs 0 0 0 0 5 27 32 32
Privacy, Driving Data and Automobile Insurance: An Economic Analysis 0 0 0 0 0 1 5 265
Privacy, Driving Data and Automobile Insurance: An Economic Analysis 0 1 1 63 2 6 15 215
Subsidizing the Competition 0 0 1 134 0 1 2 666
The Evolution of A Microcredit Institution: The Irish Loan Funds, 1720 - 1920 1 1 6 298 6 15 53 1,398
Total Working Papers 1 3 15 1,727 15 59 136 8,723


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A National Formulary for Canada 1 1 4 542 2 2 16 4,067
A contractual approach to the gray market 0 0 1 113 2 6 16 368
Co-authorship and the output of academic economists 1 1 2 55 2 2 9 199
Competition policy in open economies 0 0 0 32 0 0 0 160
Generic Drug Pricing and Procurement: A Policy for Alberta 0 0 1 3 1 1 2 11
Governance of electricity transmission systems 0 1 1 78 1 3 5 197
How do Brands’ “Own Generics” Affect Pharmaceutical Prices? 2 3 5 179 3 5 13 451
Industrial Concentration, Output, and Trade: An Empirical Exploration 0 0 0 31 0 1 1 85
Making Sure Orphan Drugs Don’t Get Left Behind 0 0 0 0 0 0 1 2
Microcredit in Prefamine Ireland 0 0 5 54 2 4 18 238
Microcredit: What can we learn from the past? 1 3 11 292 3 6 22 817
Microfinance and Famine: The Irish Loan Funds during the Great Famine 0 0 2 92 0 1 7 410
Newton's First Law as Applied to Pharmacies: Why Entry Order Matters for Generics 0 1 1 4 0 3 4 14
Preliminary Injunctions and Damage Rules in Patent Law 0 0 0 69 1 3 6 315
Price‐cap Regulation, Uncertainty and the Price Evolution of New Pharmaceuticals 0 1 2 9 0 1 2 27
Strategic Implications of Learning by Doing 0 0 0 84 0 0 5 546
Sustainable Financing of Innovative Therapies: A Review of Approaches 2 2 2 5 2 2 4 20
The Anti-Competitive Effects of Brand-Controlled "Pseudo- Generics" in the Canadian Pharmaceutical Market 1 1 3 222 2 5 13 685
The Role of Local Depositors in Controlling Expenses in Small‐Scale Financial Intermediation: An Empirical Analysis 0 0 1 14 0 1 3 73
The importance of being first: evidence from Canadian generic pharmaceuticals 1 2 5 284 4 8 11 661
The large-scale integration of wind generation: Impacts on price, reliability and dispatchable conventional suppliers 2 2 5 49 2 4 8 135
The life-cycle of a microfinance institution: the Irish loan funds 0 3 9 143 0 3 17 405
The path of least resistance: Paying for antibiotics in non-human uses 0 0 0 3 2 2 3 21
Total Journal Articles 11 21 60 2,357 29 63 186 9,907


Statistics updated 2019-10-05